Compare LGND & BETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGND | BETA |
|---|---|---|
| Founded | 1987 | 2017 |
| Country | United States | United States |
| Employees | 68 | 1008 |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | N/A | N/A |
| Metric | LGND | BETA |
|---|---|---|
| Price | $299.86 | $18.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $256.29 | $35.25 |
| AVG Volume (30 Days) | 354.1K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.25 | $14.75 |
| Revenue Next Year | $19.41 | $918.13 |
| P/E Ratio | $76.27 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $131.67 | $13.43 |
| 52 Week High | $326.63 | $36.43 |
| Indicator | LGND | BETA |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 52.34 |
| Support Level | $290.20 | $14.29 |
| Resistance Level | $326.63 | $19.22 |
| Average True Range (ATR) | 10.96 | 1.20 |
| MACD | -3.74 | 0.05 |
| Stochastic Oscillator | 24.94 | 42.58 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
BETA Technologies Inc is an aerospace company. The group has developed an electric aircraft platform and propulsion systems that are positioned to transform the aviation industry forward into a new phase of growth. It designs, manufactures, and sells high-performance electric aircraft, modern electric propulsion systems, charging systems, and components. The group also invested in the underlying infrastructure of this breakthrough technology, which is critical to bringing electric aviation to life. The group has developed a differentiated presence in North America and is well-positioned to expand globally. Its products and services are Aircraft, Charge, Motor, Battery, Flight Controls, and Training. It has one operating segment: Development and Manufacturing of Electric Aircraft.